These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32338425)

  • 1. Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.
    Pollard S; Kalloger S; Weymann D; Sun S; Nuk J; Schrader KA; Regier DA
    Health Expect; 2020 Aug; 23(4):884-892. PubMed ID: 32338425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
    Raymond VM; Everett JN
    Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
    Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
    Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach.
    Pollard S; Weymann D; Loewen R; Nuk J; Sun S; Schrader KA; Hessels C; Regier DA
    Health Expect; 2023 Apr; 26(2):774-784. PubMed ID: 36660874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
    Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
    BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
    Lewis KM
    Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for clinical implementation of screening for hereditary cancer syndromes.
    Heald B; Marquard J; Funchain P
    Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
    Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
    Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?
    Silver EL; Niell-Swiller M
    Curr Opin Obstet Gynecol; 2022 Feb; 34(1):36-40. PubMed ID: 34967813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
    Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
    Cragun D; Beckstead J; Farmer M; Hooker G; Dean M; Matloff E; Reid S; Tezak A; Weidner A; Whisenant JG; Pal T
    BMC Cancer; 2021 Oct; 21(1):1099. PubMed ID: 34645413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    King E; Mahon SM
    Clin J Oncol Nurs; 2017 Oct; 21(5):589-598. PubMed ID: 28945723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
    Meiser B; Storey B; Quinn V; Rahman B; Andrews L
    J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of the oncogenetic molecular counselling in adults whith familial cancer].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Rev Med Inst Mex Seguro Soc; 2016; 54(3):364-74. PubMed ID: 27100983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.